Rockefeller Capital Management
PRNB

Rockefeller Capital Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Rockefeller Capital Management’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-150
Closed -$9K – 2749
2020
Q1 		$9K Hold
150
– – ﹤0.01% 1789
2019
Q4 		$8K Hold
150
– – ﹤0.01% 1686
2019
Q3 		$4K Hold
150
– – ﹤0.01% 1708
2019
Q2 		$5K Hold
150
– – ﹤0.01% 1448
2019
Q1 		$5K Buy
+150
New +$4.77K ﹤0.01% 1650

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rockefeller Capital Management's PRNB Position: Q2 2020 in Review

Rockefeller Capital Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q2 2020, closing a stake of 150 shares — an estimated $9K sold.

Rockefeller Capital Management first reported a position in PRNB in Q1 2019 and held it in 5 quarters. The position peaked at $9K in Q1 2020. 137 funds tracked by Wall St. Rank hold PRNB as of Q2 2020.

  • Rockefeller Capital Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 150 Principia Biopharma Inc. Common Stock shares in Q2 2020, an estimated $9K.
  • Rockefeller Capital Management first reported a position in Principia Biopharma Inc. Common Stock in Q1 2019 and held it in 5 quarters.
  • Rockefeller Capital Management's Principia Biopharma Inc. Common Stock position peaked at $9K in Q1 2020.
  • 137 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q2 2020.

Based on Rockefeller Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.